Abstract
Calcineurin (CN) is a heterodimer of a catalytic subunit, calcineurin A (CNA), and a regulatory subunit (CNB). Here, we find that the mechanism by which CNB regulates CNA depends on the substrate involved. The regulation mechanism involving tau and its truncation segments is distinct from that involving RII peptide, and the efficiencies of CNA to dephosphorylate tau are constant regardless of whether CNB was present or not. The findings shed some light on the role of CNB in controlling phosphorylation of tau in vivo and the pathogenesis of tauopathies such as Alzheimers Disease.
Keywords: Calcineurin A subunit, calcineurin B subunit, tau, RII peptide, dephosphorylation, Alzheimer's Disease
Protein & Peptide Letters
Title: Different Regulation Modes of Calcineurin Regulatory Subunit on Its Catalytic Subunit with RII Peptide and Tau as Substrates
Volume: 16 Issue: 2
Author(s): Da-yu Yu, Nan Qiao, Ping Liu and Qun Wei
Affiliation:
Keywords: Calcineurin A subunit, calcineurin B subunit, tau, RII peptide, dephosphorylation, Alzheimer's Disease
Abstract: Calcineurin (CN) is a heterodimer of a catalytic subunit, calcineurin A (CNA), and a regulatory subunit (CNB). Here, we find that the mechanism by which CNB regulates CNA depends on the substrate involved. The regulation mechanism involving tau and its truncation segments is distinct from that involving RII peptide, and the efficiencies of CNA to dephosphorylate tau are constant regardless of whether CNB was present or not. The findings shed some light on the role of CNB in controlling phosphorylation of tau in vivo and the pathogenesis of tauopathies such as Alzheimers Disease.
Export Options
About this article
Cite this article as:
Yu Da-yu, Qiao Nan, Liu Ping and Wei Qun, Different Regulation Modes of Calcineurin Regulatory Subunit on Its Catalytic Subunit with RII Peptide and Tau as Substrates, Protein & Peptide Letters 2009; 16 (2) . https://dx.doi.org/10.2174/092986609787316243
DOI https://dx.doi.org/10.2174/092986609787316243 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Analysis the Effectiveness of Oral Massage Using Sono-elastography
Neuroscience and Biomedical Engineering (Discontinued) Changes in Speech Chunking in Reading Aloud is a Marker of Mild Cognitive Impairment and Mild-to-Moderate Alzheimer’s Disease
Current Alzheimer Research Formulation and Evaluation of α-Pinene Loaded Self-emulsifying Nanoformulation for <i>In-Vivo</i> Anti-Parkinson's Activity
Recent Patents on Nanotechnology Therapeutic Potential of Essential Oil-based Microemulsions: Reviewing State-of-the-art
Current Drug Delivery Molecular Mechanisms of Inherited Arrhythmias
Current Genomics The Suicidal Risks and Treatments, Seek Medications from Multi-disciplinary
Central Nervous System Agents in Medicinal Chemistry Editorial (Thematic Issue: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets)
Current Alzheimer Research ATP-Binding Cassette Efflux Transporters in Human Placenta
Current Pharmaceutical Biotechnology Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry Application of Nanobioinformatics in Medical Science – A Probable Therapy
Current Bioinformatics Schizophrenia: Redox Regulation and Volume Neurotransmission
Current Neuropharmacology Immune Abnormalities and Endotoxemia in Patients with Ulcerative Colitis and in Their First Degree Relatives: Attempts at Neutralizing Endotoxin- Mediated Effects
Current Pharmaceutical Design Treatment Considerations in the Forensic Patient with Schizophrenia
Current Pharmaceutical Design Small Neuroscience: The Nanostructure of the Central Nervous System and Emerging Nanotechnology Applications
Current Nanoscience MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14
Current Neurovascular Research Neuronal Cell Death in Alzheimers Disease and a Neuroprotective Factor, Humanin
Current Neuropharmacology Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia
Current Topics in Medicinal Chemistry Establishment of Method for the Determination of Aggregated α-Synuclein in DLB Patient Using RT-QuIC Assay
Protein & Peptide Letters Alzheimers and Dementia in the Oldest-Old: A Century of Challenges
Current Alzheimer Research New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases
Current Medicinal Chemistry